Vigil Neuroscience Inc (NASDAQ:VIGL) shares, rose in value on Friday, June 20, without any change to the previous day’s close as strong demand from buyers drove the stock to $7.92.
Actively observing the price movement in the last trading, the stock closed the session at $7.92, falling within a range of $7.9011 and $7.93. The value of beta (5-year monthly) was 3.45. Referring to stock’s 52-week performance, its high was $7.95, and the low was $1.31. On the whole, VIGL has fluctuated by 219.35% over the past month.
With the market capitalization of Vigil Neuroscience Inc currently standing at about $369.64 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-07.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VIGL’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of VIGL currently trading nearly 0.41% and 79.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 88.71, while the 7-day volatility ratio is showing 0.24% which for the 30-day chart, stands at 27.43%. Furthermore, Vigil Neuroscience Inc (VIGL)’s beta value is 3.45, and its average true range (ATR) is 0.17.
A comparison of Vigil Neuroscience Inc (VIGL) with its peers suggests the former has fared considerably weaker in the market. VIGL showed an intraday change of 0.00% in last session, and over the past year, it grew by 86.79%%.
Data on historical trading for Vigil Neuroscience Inc (NASDAQ:VIGL) indicates that the trading volumes over the past 10 days have averaged 2.38 and over the past 3 months, they’ve averaged 1.22 million. According to company’s latest data on outstanding shares, there are 46.67 million shares outstanding.
Nearly 32.98% of Vigil Neuroscience Inc’s shares belong to company insiders and institutional investors own 52.34% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.37 million shares as on 2025-05-30, resulting in a short ratio of 0.17. According to the data, the short interest in Vigil Neuroscience Inc (VIGL) stood at 103.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.36 million. The stock has risen by 365.88% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VIGL stock heading into the next quarter.
